Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Author(s) -
Daniel L. Rolnik,
D. Wright,
Liona C. Poon,
N. O’Gorman,
Argyro Syngelaki,
C. de Paco Matallana,
Ranjit Akolekar,
S. Cicero,
D. Janga,
Mandeep Singh,
F. S. Molina,
Nicola Persico,
Jacques Jani,
W. Plasencia,
George Papaioannou,
Kinneret Tenenbaum-Gavish,
Hamutal Meiri,
Sveinbjörn Gizurarson,
Kate Maclagan,
K. H. Nicolaides
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1704559
Subject(s) - medicine , preeclampsia , aspirin , placebo , gestation , odds ratio , pregnancy , obstetrics , confidence interval , incidence (geometry) , randomized controlled trial , relative risk , genetics , alternative medicine , pathology , biology , physics , optics
Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom